Dive into the extensive array of medicine grounded in evidence.
We are excited to showcase the following CME topics in an on-demand format as the program was thoughtfully crafted to touch on all facets of family medicine:
|
|
Accreditation and Credit Statements
The American College of Osteopathic Family Physicians (ACOFP) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
The American College of Osteopathic Family Physicians (ACOFP) designates this enduring activity for a maximum of 40 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.
The American College of Osteopathic Family Physicians (ACOFP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ACOFP designates this enduring activity for a maximum of 40 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*AOA Diplomates: Once you are ready for ACOFP to report your credits to AOA, please go to the bottom of this section to the overall certificate and claim all of those credits. If you claim before completing the full amount from all of the courses just go back and re-claim the overall certificate so it can be updated during subsequent reporting.
Disclosure Information
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP requires that individuals in a position to control the content of an educational activity disclose all financial relationships with any ineligible company. ACOFP reviews the disclosed relationship and mitigates all relevant financial relationships to ensure independence, objectivity, balance, and scientific rigor in all their educational programs.
The below individuals disclosed relevant financial relationships. All other individuals in control of the content of this activity have no relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships listed have been mitigated as noted.
| Name of Individual |
Role in Activity | Name of Ineligible Company(ies) | Nature of Relationship(s) | Mitigation Mechanism(s) Implemented |
| Drew Bird, MD |
Speaker | Aimmune Therapeutics AllerGenis DBV Technologies Genetech Infinant Health Novartis Siolta |
Research Consultant Consultant Consultant Research Consultant Research |
Peer Content Review by Planner with no financial relationships |
| Susan Medalie, DO |
Speaker | Organon | Speaker's Bureau | Peer Content Review by Planner with no financial relationships |
| Nicholas Pennings, DO, FOMA, FACOFP |
Speaker | Eli Lily Gelesis Medifast Novo Nordisk |
Consultant Consultant Contractor Consultant |
Peer Content Review by Planner with no financial relationships |
| David Podwall, MD | Speaker | NK Max | Consultant | Peer Content Review by Planner with no financial relationships |
| Jay Shubrook, DO |
Speaker | Abbott Bayer Eli Lilly Madrigal Nevro Novo Nordisk |
Consultant Advisory Brd. Advisory Brd. Advisory Brd. Advisory Brd. Consultant |
Peer Content Review by Planner with no financial relationships |
| Brittanie N. West, DO |
Speaker | Organon | Speaker's Bureau | Peer Content Review by Planner with no financial relationships |
Pricing
Member: $950
Non-member: $1,300
Interested in becoming an ACOFP member? Join now!